Thomas Tillis (R-NC)

Medical Supply Chain Resiliency Act

S. 998 · Senate bill Foreign Trade and International Finance

A Republican bill with 2 Democratic cosponsors · See all 3 cosponsors

Last activity — Read twice and referred to the Committee on Finance.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The Medical Supply Chain Resiliency Act aims to authorize the President to enter into trade agreements with trusted partners to improve the security of medical goods. This legislation seeks to diversify supplier networks to prevent shortages seen during the COVID-19 pandemic. It provides a framework for the reciprocal elimination of duties and import restrictions on medical devices and pharmaceuticals. The bill focuses on enhancing supply chain security through regulatory cooperation and intellectual property protection. Additionally, it establishes oversight mechanisms for Congress to review and potentially disapprove these trade agreements.

Yes· 3 of 13

  • Scored +8

    Does this make the country readier for the next outbreak?

    The bill specifically targets strengthening supply chains to prepare for future public health emergencies.

  • Scored +7

    Does this make trade with other countries easier?

    The bill facilitates more efficient trade by reducing duties and regulatory barriers for medical goods.

  • Scored +6

    Does this strengthen ties with allied countries?

    The bill focuses on establishing and strengthening trade relationships with trusted international partners.

The opposite

No question was scored the opposite.